Control of uremic bone disease: Role of vitamin D analogs
- 1 May 2002
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 61 (80) , S143-S148
- https://doi.org/10.1046/j.1523-1755.61.s80.24.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidismKidney International, 1997
- A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidismNephrology Dialysis Transplantation, 1996
- Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins.Journal of Clinical Investigation, 1995
- Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.Journal of Clinical Investigation, 1993
- 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogsKidney International, 1989
- Diminished parathyroid 1,25(OH)2D3 receptors in experimental uremiaKidney International, 1987
- Reduced Binding of [3H]l,25-Dihydroxyvitamin D3in the Parathyroid Glands of Patients with Renal FailureNew England Journal of Medicine, 1987
- Altered divalent ion metabolism in early renal failure: Role of 1,25(OH)2DKidney International, 1985
- Circulating vitamin D metabolite concentrations in childhood renal diseasesKidney International, 1982
- SERUM CONCENTRATIONS OF METABOLITES OF VITAMIN D IN PATIENTS WITH CHRONIC RENAL FAILURE (CRF). CONSEQUENCES FOR THE TREATMENT WITH 1‐α‐HYDROXY‐DERIVATIVESClinical Endocrinology, 1981